IRIS
VACCA, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 200
AS - Asia 86
EU - Europa 67
AF - Africa 4
Totale 357
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 197
SG - Singapore 42
FI - Finlandia 20
HK - Hong Kong 20
IT - Italia 19
CN - Cina 16
NL - Olanda 8
GB - Regno Unito 6
IN - India 6
RU - Federazione Russa 5
CI - Costa d'Avorio 4
CA - Canada 3
DE - Germania 3
IE - Irlanda 2
IR - Iran 2
SE - Svezia 2
AT - Austria 1
UA - Ucraina 1
Totale 357
Salva come PNG Salva come JPEG
Città #
Chandler 35
Singapore 35
Santa Clara 31
Hong Kong 20
Ashburn 14
Millbury 11
Princeton 11
Helsinki 9
Amsterdam 8
Beijing 6
Des Moines 6
Naples 5
Wilmington 5
Nanjing 4
Napoli 4
San Mateo 4
Augusta 3
Falkenstein 3
Milan 2
Nanchang 2
Ottawa 2
Salerno 2
Seattle 2
Tianjin 2
Ardabil 1
Boydton 1
Cardito 1
Florence 1
Hebei 1
Innsbruck 1
Leawood 1
Norwalk 1
Pune 1
Redmond 1
Shenyang 1
Toronto 1
Totale 238
Salva come PNG Salva come JPEG
Nome #
Comparative effects of mesoglycan and ticlopidine treatment on some coagulative parameters in patients with previous ischemic stroke: Results of a randomized controlled trial 44
Anti-JC virus antibodies index and JCV DNA concordance and markers of active viral replication: true exposure to JCV virus in natalizumab treated patients. In MULTIPLE SCLEROSIS JOURNAL (Vol. 19, No. 11, pp. 495-496). 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND: SAGE PUBLICATIONS LTD. 42
An open label randomised clinical trial of atorvastatin in combination with IFN beta-1a in active MS patients: 12 months results. 41
Switching disease-modifying therapies in multiple sclerosis: follow-up of 108 patients. In MULTIPLE SCLEROSIS (Vol. 11, pp. S159-S159). 338 EUSTON ROAD, LONDON NW1 3BH, ENGLAND: HODDER ARNOLD, HODDER HEADLINE PLC. 39
JCV antibodies index on natalizumab treatment: fluctuations and seroconversion. 38
JCV antibodies seroconversion on natalizumab treatment and predictive factors: preliminary data. 36
Endothelin-1 serum levels are increased in patients with multiple sclerosis. 33
Serum levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in relapsing and secondary progressive IFN beta treated MS patients 30
Relationship between Clinical Aspects in Early Phases of Relapsing-Remitting Multiple Sclerosis and Subsequent Brain Volume Changes 29
Correlation of disease severity and regional brain tissue loss in relapsing-remitting multiple sclerosis: a voxel-based morphometry study in a large population 29
Serum levels of insulin like growth factor-1 and insulin like growth factor binding protein-3 in relapsing and secondary progressive multiple sclerosis 28
Totale 389
Salva come PNG Salva come JPEG
Categoria #
all - tutte 1.742
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.742
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010 0 0 0 0 0 0 3 0 0 0 7 0
2020/202114 1 0 0 0 0 0 0 0 0 0 13 0
2021/202242 0 0 0 0 0 2 0 5 2 6 10 17
2022/202381 11 3 4 1 16 11 0 3 7 10 5 10
2023/202449 2 9 6 3 4 8 2 4 0 0 7 4
2024/2025120 14 21 1 0 11 52 21 0 0 0 0 0
Totale 389